Chronic polyarthritis as the first manifestation of juvenile systemic lupus erythematosus patients

E G N Cavalcante1, N E Aikawa, R G Lozano

  • 1Pediatric Rheumatology Unit, Children's Hospital, São Paulo, Brazil.

Lupus
|June 4, 2011
PubMed

Insights

Chronic polyarthritis is a rare manifestation in juvenile systemic lupus erythematosus (JSLE). This study highlights the "rhupus" overlap, a distinct JSLE subgroup with poor response to NSAIDs alone.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Systemic Autoimmune Diseases

Background:

  • Juvenile Systemic Lupus Erythematosus (JSLE) is a complex autoimmune condition affecting children.
  • Chronic polyarthritis is an uncommon but significant manifestation in JSLE patients.
  • Understanding JSLE's diverse clinical presentations is crucial for effective management.

Purpose of the Study:

  • To determine the prevalence of chronic polyarthritis in juvenile systemic lupus erythematosus (JSLE).
  • To characterize the clinical features, treatment strategies, and outcomes of JSLE patients with chronic polyarthritis.
  • To investigate the 'rhupus' overlap syndrome in the context of JSLE.

Main Methods:

  • Retrospective analysis of 5419 patients from a Pediatric Rheumatology Unit (1983-2010).
  • Identified 271 patients with JSLE (ACR criteria) and evaluated for chronic polyarthritis.
  • Defined 'rhupus' as overlap between juvenile idiopathic arthritis (ILAR criteria) and JSLE; assessed clinical, laboratory, and radiographic data.

Main Results:

  • Chronic polyarthritis occurred in 2.6% (7/271) of JSLE patients, presenting initially in all cases.
  • Three patients exhibited 'rhupus' with chronic polyarthritis, rheumatoid factor, autoantibodies, and radiographic abnormalities.
  • Treatment involved NSAIDs, prednisone, antimalarials; three 'rhupus' patients required immunosuppressants due to non-responsiveness.

Conclusions:

  • Chronic polyarthritis is a rare but distinct manifestation in pediatric lupus.
  • 'Rhupus' in JSLE may represent a unique clinical subgroup with a poorer prognosis and limited response to NSAIDs.
  • Further research into potential genetic factors for this JSLE subtype is warranted.
Abstract

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...